在动物致癌性研究中的统计分析中结合初级瘤的指南
Charlotte Keenan1, Muthafar Al-Haddawi2, Jean-Guy Bienvenu3
1C.M. Keenan ToxPath Consulting, Doylestown, Pennsylvania, USA.
Toxicologic pathology
|March 6, 2024
概括
该指南通过为瘤类型提供协调的层次结构,帮助审稿人统计分析非临床瘤数据. 它将瘤命名标准化,以改善数据解释和监管提交.
科学领域:
- 毒理学病理学 毒理学病理学
- 生物统计学 生物统计学
- 监管科学 监管科学
背景情况:
- 非临床瘤数据分析需要标准化命名来准确的统计解释.
- 现有的瘤术语可能是不同的,复杂的数据聚合和分析.
- 美国食品和药物管理局 (FDA) 要求对瘤数据的解释采用统一的方法.
研究的目的:
- 创建一个瘤组合指南,用于对非临床瘤数据的统计分析.
- 将国际命名和诊断标准协调 (INHAND) 中的瘤名称与非临床数据交换标准 (SEND) 中的NEOPLASM控制术语 (CT) 相关联.
- 帮助药理学/毒理学审稿人,生物统计学家和病理学家解释和分析瘤数据.
主要方法:
- 为瘤类型和类别制定更高层次的层次结构.
- INHAND瘤名称与SEND NEOPLASM CT代码的相关性.
- 在表格格式中提供说明和示例,以便在结合瘤数据时做出明智的决定.
- 基于文学科学标准结合瘤类型的策略.
主要成果:
- 建立了一个全面的指南,将INHAND和SEND瘤术语联系起来.
- 该指南促进了结合瘤数据进行统计分析的知情决策.
- 它为解释非临床瘤数据提供了一个标准化的框架.
结论:
- 瘤组合指南增强了对非临床瘤数据的统计分析.
- 它促进报告和解释毒理病理学发现的一致性和清晰性.
- 该指南将更新以反映不断变化的SEND和INHAND术语.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
06:21Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
11.2K
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
